SLHN:SIXSwiss Life Holding AG Analysis

Swiss Life’s share price is trading just above the 20‑day SMA of 891 and comfortably above the 50‑day SMA of 878, indicating a short‑term bullish bias despite a bearish MACD histogram and a MACD line that sits below its signal. The RSI at 40 suggests the stock is not yet oversold, while a 30‑day volatility of nearly 20 % and a very low beta of 0.22 point to limited systematic risk. Valuation is mixed: the trailing PE of 19.7 exceeds the industry average of 16.7, hinting at a premium, yet the DCF‑derived fair value of over 2,900 CHF dwarfs the current price near 857 CHF, implying substantial upside. The balance sheet shows abundant cash of roughly 84 bn CHF against debt of 15 bn CHF, though the debt‑to‑equity ratio is elevated, and the company does not pay a dividend. Operating margins are solid at around 16 % with a respectable ROE of 16.5 %, supporting the case for value‑oriented investors. Overall, the technical backdrop is cautiously optimistic, the valuation gap is compelling, and the financial fundamentals are robust, making the stock a candidate for accumulation.